Importantly, we elucidated that tumor-derived exosomes-enriched miR-185-3p mediates tumor cell proliferation, colony formation, tumor growth, and drug response by targeting its downstream effector RAB25 that have potential therapeutic efficacy for HNSCC treatment. This evidence concerns the gene RAB25 and neoplasm.